Expression of CD28 on the CD8~+ lymphocytes in patient with multiple sclerosis
Bin Xia
Abstract
Bin Xia
Abstract
Objective To analyze the expression levels of CD28 on the CD8 + lymphocytes from patients with multiple sclerosis (MS).Methods The percentage of CD28 +,CD8 +CD28 - and CD8 +CD28 + were determined by flow cytometry on peripheral blood lymphocytes from 16 patients with relapsing MS and 20 controls. Results Compared to control group, the percentage of CD8 +CD28 - lymphocytes in relapses MS group decreased, the percentage of CD28 + and CD8 +CD28 + did not significantly change. Methylprednisolone treatment did not cause any significant changes of CD28 +,CD8 +CD28 - and CD8 +CD28 +. Conclusion The CD8 cell involved in MS pathogenesis were CD8 +CD28 - cell.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To analyze the expression levels of CD28 on the CD8 + lymphocytes from patients with multiple sclerosis (MS).Methods The percentage of CD28 +,CD8 +CD28 - and CD8 +CD28 + were determined by flow cytometry on peripheral blood lymphocytes from 16 patients with relapsing MS and 20 controls. Results Compared to control group, the percentage of CD8 +CD28 - lymphocytes in relapses MS group decreased, the percentage of CD28 + and CD8 +CD28 + did not significantly change. Methylprednisolone treatment did not cause any significant changes of CD28 +,CD8 +CD28 - and CD8 +CD28 +. Conclusion The CD8 cell involved in MS pathogenesis were CD8 +CD28 - cell.
Key concepts: CD28, CD8, Flow cytometry, Multiple sclerosis, Pathogenesis, Immunology, Medicine, Biology